HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

Update: 2025-04-03

Description

Drs Kathleen N Moore and Alessandro D Santin and moderator Dr David M O’Malley summarize and share their perspectives on data guiding the management of HER2-positive gynecologic cancers that were presented at the Society of Gynecologic Oncology 2025 annual meeting.

CME information and select publications here.

Comments

In Channel

Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm

2025-08-2152:35

Gynecologic Cancers — Year in Review Series on Relevant New Datasets and Advances

2025-08-0259:34

Oncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches

2025-07-2153:51

Ovarian and Endometrial Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

2025-07-0101:59:45

For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS Congress

2025-06-2401:31:27

For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress

2025-06-0601:28:47

Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit

2025-05-1148:41

Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

2025-04-1701:29:33

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

2025-04-0301:29:21

Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers

2024-12-1746:41

Oncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer

2024-08-2252:37

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology

2024-07-2659:17

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series

2024-02-1659:53

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series

2024-01-2401:01:37

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition

2023-12-2001:05:36

Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers

2023-11-2101:01:25

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series

2023-11-0201:03:54

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series

2023-10-1001:02:10

Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer

2023-09-2621:40

Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

2023-08-1143:12

00:00

1.0x

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

#box-pro-ellipsis-175890648191521{-webkit-line-clamp:2;}HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️